Vitamin C vs placebo
The review found no eligible studies for this question.
- Vitamin C supplementation for prevention and treatment of pneumonia 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Palivizumab leads to lower hospitalisation due to RSV infection compared with placebo, no intervention or standard care (high certainty).
Palivizumab showed no clear difference in mortality compared with placebo, no intervention or standard care (moderate certainty).
Palivizumab showed no clear difference in adverse events compared with placebo, no intervention or standard care (moderate certainty).
Palivizumab probably leads to lower hospitalisation due to respiratory‐related illness compared with placebo, no intervention or standard care (moderate certainty).
Palivizumab may leads to lower RSV infection compared with placebo, no intervention or standard care (low certainty).
Palivizumab leads to lower number of wheezing days compared with placebo, no intervention or standard care (high certainty).
Probiotic probably leads to lower proportion of children with AOM (overall) compared with placebo (moderate certainty).
Probiotic probably leads to lower proportion of children with AOM: children not prone to AOM compared with placebo (moderate certainty).
Probiotic showed no clear difference in proportion of children with AOM: children prone to AOM compared with placebo (high certainty).
The review found no eligible studies for this question.
Probiotic showed no clear difference in adverse events compared with placebo (low certainty).
Probiotic probably leads to lower difference in the use of antibiotics compared with placebo (moderate certainty).
Probiotic probably leads to lower difference in proportion of children with other infections compared with placebo (moderate certainty).
Inactivated parenteral influenza vaccine probably leads to lower influenza assessed by laboratory confirmation Timing of assessment:… compared with placebo or 'do nothing' (moderate certainty).
Inactivated parenteral influenza vaccine probably leads to lower influenza‐like illness assessed by subjective report Timing of… compared with placebo or 'do nothing' (moderate certainty).
Inactivated parenteral influenza vaccine showed no clear difference in hospitalisations Timing of assessment: single influenza season compared with placebo or 'do nothing' (low certainty).